Innoviva Inc.

Last updated September 27, 2026

Organization details

Legal name
Innoviva Inc.
Former names
Theravance Inc Advanced Medicine Inc
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2834 — Pharmaceutical Preparations
Jurisdiction of incorporation
Delaware
Headquarters city
Burlingame
Headquarters state / province
California
Headquarters country
United States
Fiscal year end
December
Ticker symbol
INVA
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001080014
EIN
94-3265960

Board of directors

Chief executives

Pavel Raifeld · Chief Executive Officer
Dates unknown

Director election results

Annual meeting of May 4, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

7 of this board's directors also sit on 6 other boards. 4 are in the same sector.

Network of Innoviva Inc.'s board connections Armata Pharmaceuticals Inc. Armata Pharmaceuticals... Amarin Corporation plc Amarin Corporation plc Alumis Inc. Alumis Inc. Aura Biosciences Inc. Aura Biosciences Inc. Lands' End Inc. Lands' End Inc. OneIM Acquisition Corp. OneIM Acquisition Corp... Deborah Birx Deborah Birx Josephine Linden Josephine Linden Jules Haimovitz Jules Haimovitz Kostas D. Odysseas Kostas D. Odysseas Mark DiPaolo Mark DiPaolo Sapna Srivastava Sapna Srivastava Sarah J. Schlesinger Sarah J. Schlesinger Innoviva Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$0
0 sales by 0 insiders
Date Insider Transaction Shares Price Value
Aug 20, 2026 Basso Stephen Officer (Chief Financial Officer) Shares withheld for tax −558 $21.00 $11,718
Aug 20, 2026 Pavel Raifeld Director, Officer (Chief Executive Officer) Shares withheld for tax −1,130 $21.00 $23,730
Aug 20, 2026 Zhen Marianne Officer (Chief Accounting Officer) Shares withheld for tax −1,127 $21.00 $23,667
May 20, 2026 Zhen Marianne Officer (Chief Accounting Officer) Shares withheld for tax −1,127 $22.24 $25,064
May 20, 2026 Basso Stephen Officer (Chief Financial Officer) Shares withheld for tax −559 $22.24 $12,432
May 20, 2026 Pavel Raifeld Director, Officer (Chief Executive Officer) Shares withheld for tax −1,130 $22.24 $25,131
May 18, 2026 Josephine Linden Director Grant or award +5,733 — —
May 18, 2026 Josephine Linden Director Grant or award +9,461 — —
May 15, 2026 Basso Stephen Officer (Chief Financial Officer) Grant or award +1,123 — —
May 15, 2026 Pavel Raifeld Director, Officer (Chief Executive Officer) Grant or award +1,123 — —
May 4, 2026 Mark DiPaolo Director Grant or award +9,786 — —
May 4, 2026 Pavel Raifeld Director, Officer (Chief Executive Officer) Grant or award +126,646 — —
May 4, 2026 Zhen Marianne Officer (Chief Accounting Officer) Grant or award +12,766 — —
May 4, 2026 Sarah J. Schlesinger Director Grant or award +9,786 — —
May 4, 2026 Basso Stephen Officer (Chief Financial Officer) Grant or award +37,994 — —

Organizations in the same sector, closest in location and size first.

Questions about Innoviva Inc.

Who is the CEO of Innoviva Inc.?

Pavel Raifeld is Innoviva Inc.'s Chief Executive Officer.

How many directors are on Innoviva Inc.'s board?

Innoviva Inc.'s board has 9 directors: Deborah Birx, Derek A. Small, Josephine Linden, Jules Haimovitz, Kostas D. Odysseas, Mark DiPaolo, Pavel Raifeld, Sapna Srivastava and Sarah J. Schlesinger.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="innoviva-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.